A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

Authors :: Mirza, M. R.
Bjorge, L.
Marme, F.
Christensen, R. DePont
Gil-Martin, M.
Auranen, A.
Ataseven, B.
Rubio, M. J.
Salutari, V.
Lund, B.
Runnebaum, I.
Redondo, A.
Lindemann, K.
Trillsch, F.
Barretina Ginesta, M. P.
Roed, H.
Lohndorf, J.
Nyvang, G-B.
Sehouli, J.
Source :: Mirza, M R, Bjorge, L, Marme, F, Christensen, R D, Gil-Martin, M, Auranen, A, Ataseven, B, Rubio, M J, Salutari, V, Lund, B, Runnebaum, I, Redondo, A, Lindemann, K, Trillsch, F, Barretina Ginesta, M P, Roed, H, Lohndorf, J, Nyvang, G-B & Sehouli, J 2020, ' A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial ', Annals of Oncology, vol. 31, no. Suppl. 4, LBA28, pp. S1160 . https://doi.org/10.1016/j.annonc.2020.08.2258
Publication Year :: 2020

Language :: English
Database :: OpenAIRE
Journal :: Mirza, M R, Bjorge, L, Marme, F, Christensen, R D, Gil-Martin, M, Auranen, A, Ataseven, B, Rubio, M J, Salutari, V, Lund, B, Runnebaum, I, Redondo, A, Lindemann, K, Trillsch, F, Barretina Ginesta, M P, Roed, H, Lohndorf, J, Nyvang, G-B & Sehouli, J 2020, ' A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial ', Annals of Oncology, vol. 31, no. Suppl. 4, LBA28, pp. S1160 . https://doi.org/10.1016/j.annonc.2020.08.2258
Accession number :: edsair.od......3062..85a6c27ca2f29b4a182da3ec7706f129

Tools